New Jersey legislation · 2026-2027 Regular Session
New Jersey A1207: Ovulation enhancing drugs/medical svc-req Medicaid coverage, cert beneficiaries
Status: Passed one chamber, September 28, 2026
Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.
What the bill says
An Act concerning Medicaid coverage for ovulation enhancing drugs and amending P.L.1968, c.413.
From the amended text, June 18, 2026:
An Act concerning Medicaid coverage for ovulation enhancing drugs and amending P.L.1968, c.413. Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1[1. Section 6 of P.L.1968, c.413 (C.30:4D-6) is amended to read as follows: 6. a. Subject to the requirements of Title XIX of the federal Social Security Act, the limitations imposed by this act and by the rules and regulations promulgated pursuant thereto, the department shall provide medical assistance to qualified applicants, including authorized services within each of the following classifications: (1) Inpatient hospital services (2) Outpatient hospital services; (3) Other laboratory and X-ray services; (4) (a) Skilled nursing or intermediate care facility services; (b) Early and periodic screening and diagnosis of individuals who are eligible under the program and are under age 21, to ascertain their physical or mental health status and the health care, treatment, and other measures to correct or ameliorate defects and chronic conditions discovered thereby, as may be provided in regulation of the Secretary of the federal Department of Health and Human Services and approved by the commissioner; (5) Physician's services furnished in the office, the patient's home, a hospital, a skilled nursing, or intermediate care facility or elsewhere. As used in this subsection, "laboratory and X-ray services" includes HIV drug resistance testing, including, but not limited …
Sponsors
- Alexander Schnall (D, 30) · primary sponsor
- Eliana Pintor Marin (D, 29) · primary sponsor
- Gary S. Schaer (D, 36) · primary sponsor
- Michael Venezia (D, 34)
- Rosaura Bagolie (D, 27)
- Carol A. Murphy (D, 7)
- Annette Quijano (D, 20)
- Roy Freiman (D, 16)
- Katie Brennan (D, 32)
- Vincent M. Kearney (D, 21)
- Luanne M. Peterpaul, Esq. (D, 11)
- Margie Donlon, M.D. (D, 11)
Latest actions
- : R/S REF SHH
- : PA (66-3-3)
- : REP 2RA
- : REP/ACA REF AAP
- : INT 1RA REF AHE
Votes
- 3RDG FINAL PASSAGE - Ovulation enhancing drugs/medical svc-req Medicaid coverage, cert beneficiaries (September 24, 2026): 66 yea, 3 nay, passed
- Assembly Appropriations Committee: Reported favorably (June 23, 2026): 13 yea, 0 nay, passed
- Assembly Health Committee: Reported with committee amendments (Aca) (June 18, 2026): 8 yea, 2 nay, passed
Subjects: HEALTH, HUMAN SERVICES - MEDICAID AND MEDICARE
Common questions
- What is A1207?
- A1207 is a bill in the New Jersey Legislature (2026-2027 Regular Session): Ovulation enhancing drugs/medical svc-req Medicaid coverage, cert beneficiaries.
- What does A1207 do?
- In its own words: An Act concerning Medicaid coverage for ovulation enhancing drugs and amending P.L.1968, c.413.
- What is the status of A1207?
- Passed one chamber as of September 28, 2026. Latest action: R/S REF SHH (September 28, 2026).
- Who sponsored A1207?
- Alexander Schnall (D, 30), with 11 co-sponsors.
- Where is the official record for A1207?
- On the New Jersey Legislature website: https://www.njleg.state.nj.us/bill-search/2026/A1207
Source: official New Jersey record. Tracked by Delilah, AI for legislation across all 50 states and Congress.